Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Role of Angiotensin-Converting Enzyme (ACE) Polymorphisms in the Risk of Development and Treatment of Diabetic Nephropathy

8 Feb 2024

Abstract excerpt

Background: Angiotensin-converting enzyme (ACE) is responsible for the production of angiotensin II, and increased production of angiotensin II is observed in diabetes. What is more, ACE polymorphisms may play a role in the development of diabetic nephropathy. The aim of this study was to assess the role of selected ACE polymorphisms (rs4343 and rs4646994) in the risk of development of diabetic nephropathy and in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chronic Kidney Disease and Diabetes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Protein Hydrolysis and Bioactive Peptides

Share to Renin-Angiotensin System Studies

Source

Identifiers

PMID: 38398308
DOI: 10.3390/jcm13040995

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Role of Angiotensin-Converting Enzyme (ACE) Polymorphisms in the Risk of Development and Treatment of Diabetic NephropathyPMID 38398308Read ↗

Association of genetic variants with diabetic nephropathySemantic proximity Read ↗

Genetic Variation in the Renin-Angiotensin System and Diabetic Nephropathy in the Tunisian Population.Semantic proximity Read ↗

MTHFR C677T, A1298C and ACE I/D polymorphisms as risk factors for diabetic nephropathy among type 2 diabetic patients.Semantic proximity Read ↗

Associations between angiotensinogen M235T polymorphisms and the risk of diabetic nephropathy: A meta-analysis.Semantic proximity Read ↗

ACE insertion/deletion polymorphism and diabetic nephropathy: clinical implications of genetic information.Semantic proximity Read ↗

The effects of angiotensinogen M235T/T174M and angiotensin type 1 receptor a1166c gene polymorphisms on the development of diabetic nephropathy in type 2 diabetes mellitus patients.Semantic proximity Read ↗

Association between Angiotensin Converting Enzyme Gene I/D and Promoter Polymorphisms and Diabetic Nephropathy in Type2 Diabetic Patients in Ismailia, EgyptSemantic proximity Read ↗

Association Between Angiotensin Converting Enzyme Insertion / Deletion Genotypes and Diabetic Nephropathy Defined by Urinary Albumin-to-Creatinine Ratio: A Systematic Review and Meta-AnalysisSemantic proximity Read ↗

ACE variants interact with the RAS pathway to confer risk and protection against type 2 diabetic nephropathy.Semantic proximity Read ↗

Genetic variants of ACE (Insertion/Deletion) and AGT (M268T) genes in patients with diabetes and nephropathy.Semantic proximity Read ↗

Association of matrix metalloproteinase-2 gene variants with diabetic nephropathy risk.Semantic proximity Read ↗

Significant association of candidate genes (AGTR1 and TGF-β1) polymorphism with diabetic nephropathy in diabetes mellitus type 2 patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.